Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Psychiatry and Mental Health

 

What is behind Korian property deals?

Care group giant Korian has signed a second property deal with another big institutional investor, in this case, BAE Systems Pension Funds. This partnership leaves Korian in control of its property whilst giving the investor protection from the volatility of the stock market and guarantees on minimum returns.
January 6, 2022

Polarising politician becomes German Federal Minister of Health

Germany has a new government - and a new Federal Minister of Health in Karl Lauterbach. HBI talks to two Germany-based sources who agree he is a politician embraced more by the public than his own party, and considers what his appointment might mean for the sector.
December 16, 2021

Ramsay buys Elysium

International hospital operator Ramsay Healthcare is entering the UK mental health hospital market with the £775m (€907m) acquisition of Elysium Healthcare.
December 16, 2021

Booster blunder puts staff at risk

The Indian government's slowness to approve booster shots is putting lives at risk - particularly those of front line medical staff whose immunity is waning. HBI speaks to a disappointed operator source in the country to find out more.
November 30, 2021

Scotland pioneers free digital mental health therapeutics

Scotland will become the first country in the world to offer digital therapeutics for insomnia and anxiety for free at a national level, after NHS Scotland announced on October 13 that it has contracted with digital therapeutics group Big Health to make its two apps available to all five million Scottish adults. Big Health’s UK Director, Dr. Charlotte Lee, tells HBI the company plans to retain its focus on insomnia and anxiety as these areas are key to good overall mental health.
October 28, 2021

Interview: Alexandra Prieux, CEO, ALCEDIAG

A pioneering blood test which helps clinicians diagnose bipolar disorder will come to market shortly. HBI catches up with Alexandra Prieux, CEO at France-based ALCEDIAG, which should be first to market with the first of what could be a series of tests.
October 27, 2021
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us